AT&S Adjusts Financial Forecasts and Plans for Ansan Plant Sale

AT&S Austria Technologie & Systemtechnik AG has updated its financial forecast for the fiscal year 2026/27 and announced strategic decisions including no plans for a capital increase and the sale of its Ansan plant, according to a statement released on May 10, 2024. The adjustments reflect a reduction in expected annual revenue from approximately €3.5 billion to around €3.1 billion, while maintaining its EBITDA margin, ROCE, net debt/EBITDA ratio, and marking a decrease in the equity ratio projection from over 30% to around 20%.

The company disclosed that ongoing market volatility has influenced its decision to forego a capital increase at this time and end discussions with potential investors. Moreover, AT&S is moving forward with obtaining binding offers for its Ansan plant in Korea, which mainly caters to the medical market, after considering non-binding proposals and noted interest levels. The plant contributed €76 million in revenue and €38 million in EBITDA in the 2023/24 financial year.

In line with these developments, AT&S has also proposed not to distribute dividends for the fiscal year 2023/24 during the forthcoming 30th Annual General Meeting scheduled for July 4, 2024. This decision contrasts with the previous year's dividend of €0.40 per share. The company will reveal its annual results for 2023/24 on May 14, 2024, and will publish the annual report on June 6, 2024.